Summary "Allergan’s depression drug Rapastinel, will be a game-changer" – Allergan CEO Brent Saunders. Cramer is bullish on Sprint-T-Mobile merger.Northrop Grumman is still a good buy. Stocks discussed on the […] Click here to view full article